
Fagron company profile
Activities of Fagron
Fagron adopts a dividend policy that takes into account the profitability of the business and any underlying growth, as well as its capital requirements and cash flows, while maintaining sufficient liquidity for pursuing its buy-and-build strategy. Accordingly, Fagron expects to reinvest the majority of its free cash flow in the next few years and to pay out a relatively low, steadily increasing level of dividends to its shareholders.
Year | Gross dividend per share |
---|---|
2019 | € 0.12 |
2018 | € 0.10 |
2017 | - |
2016 | - |
2015 | € 1.00 |
2014 | € 0.72 |
2013 | € 0.60 |
2012 | € 0.50 |
2011 | € 0.44 |
Fagron is the leading global pharmaceutical compounding company, bringing customized pharmaceutical care to hospitals, pharmacies, clinics and patients in 35 countries worldwide.